RadianceTx Raises $1 Million First Tranche to Develop Novel Glaucoma Therapy

RadianceTx announced a $1 million first tranche closing of a targeted $7 million round of financing. The investment will be used to fund development of the company’s Beta Ophthalmic System for delivery of beta irradiation therapy to improve glaucoma surgery outcomes.

Read the article in eyewire.news.